Clinical Trials on First Line WT KRAS mCRC in Russian Federation

Total 2 results

  • EMD Serono Research & Development Institute, Inc.
    Merck KGaA, Darmstadt, Germany
    Completed
    First Line Non-Small Cell Lung Cancer
    Spain, United States, Hungary, Israel, China, Korea, Republic of, Taiwan, Czechia, Russian Federation, Australia, Brazil, Lebanon, Serbia, Thailand, Canada, Slovakia, Ukraine, Bulgaria, Italy, Netherlands, New Zealand, Poland, Belgium, Turk... and more
  • AstraZeneca
    Merck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.
    Active, not recruiting
    Advanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum Chemotherapy
    Korea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
3
Subscribe